APA (7th ed.) Citation

Mohammad Al‐Mahdi Al‐Karagholi, Jakob Møller Hansen, Dalia Abou‐Kassem, Anna Koldbro Hansted, Kumari Ubhayasekera, Jonas Bergquist, . . . Messoud Ashina. (2021). Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers. Wiley.

Chicago Style (17th ed.) Citation

Mohammad Al‐Mahdi Al‐Karagholi, Jakob Møller Hansen, Dalia Abou‐Kassem, Anna Koldbro Hansted, Kumari Ubhayasekera, Jonas Bergquist, László Vécsei, Inger Jansen‐Olesen, and Messoud Ashina. Phase 1 Study to Access Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Kynurenine in Healthy Volunteers. Wiley, 2021.

MLA (9th ed.) Citation

Mohammad Al‐Mahdi Al‐Karagholi, et al. Phase 1 Study to Access Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Kynurenine in Healthy Volunteers. Wiley, 2021.